Neuroimaging correlates and prognostic utility of accelerated long‐term forgetting in presymptomatic autosomal dominant Alzheimer's disease
Our results suggest that ALF in presymptomatic ADAD is related to early focal structural changes in the PFC, but not the MTL. Follow-up demonstrated that ALF severity is not only associated with the presence of AD pathology but also is predictive of clinical onset, identifying those at highest risk of imminent decline. ALF testing is a biologically relevant measure that offers promise in aiding presymptomatic trial recruitment, as a presymptomatic cognitive endpoint, and potentially as a screening tool in the wider population.
Authors
- Rachana Tank (ORCID: https://orcid.org/0000-0002-4771-6685)
- Helen Rice
- Philip SJ. Weston
- Kirsty Lu
- Duncan Alston
- Nicholas Magill (ORCID: https://orcid.org/0000-0002-5138-3166)
- Damien Ferguson
- Art O'connor
- Chloe Young
- Christopher S Parker
- Sebastian J Crutch
- Ian B. Malone
- Nick C Fox
Institutions
- University of London (GB)
- London School of Hygiene & Tropical Medicine (GB)
- UK Dementia Research Institute (GB)
- NIHR Queen Square Dementia Biomedical Research Unit (GB)
- The London College (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- University College London (GB)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70857_105700
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00